Literature DB >> 16326420

beta-Carboline alkaloid suppresses NF-kappaB transcriptional activity through inhibition of IKK signaling pathway.

Jong Woo Yoon1, Jae Ku Kang, Kang Ro Lee, Hyang Woo Lee, Jeung Whan Han, Dong Wan Seo, Yong Kee Kim.   

Abstract

Nuclear factor (NF)-kappaB transcription factors play an evolutionarily conserved and critical role in the triggering and coordination of both innate and adaptive immune responses. Therefore, there is intense interest in understanding the regulation of this transcription factor in the context of various diseases. Studies investigated the suppression mechanism of NF-kappaB signaling pathways by a beta-carboline alkaloid (C-1) in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. beta-Carboline alkaloid decreased the level of inducible nitric oxide sythase (iNOS) protein and NOS promoter activities in a concentration-dependent manner. This effect was accompanied by the reduction of NF-kappaB DNA binding activity as well as NF-kappaB nuclear translocation. In addition, beta-carboline alkaloid reduced the degradation and phosphorylation of IkappaB, and attenuated IKK activity in LPS-stimulated RAW 264.7 cells. Taken together, these results indicate that beta-carboline alkaloid has the capability to suppress NF-kappaB signaling pathway through inhibition of IKK activity in LPS-stimulated RAW 264.7 cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326420     DOI: 10.1080/15287390491009110

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  4 in total

1.  A novel carboline derivative inhibits nitric oxide formation in macrophages independent of effects on tumor necrosis factor α and interleukin-1β expression.

Authors:  Ana Cristina G Grodzki; Bhaskar Poola; Nagarekha Pasupuleti; Michael H Nantz; Pamela J Lein; Fredric Gorin
Journal:  J Pharmacol Exp Ther       Date:  2014-12-23       Impact factor: 4.030

2.  Discovery of a tetrazolyl β-carboline with in vitro and in vivo osteoprotective activity under estrogen-deficient conditions.

Authors:  Anirudha Karvande; Shahnawaz Khan; Irfan Khan; Deepti Singh; Vikram Khedgikar; Priyanka Kushwaha; Naseer Ahmad; Priyanka Kothari; Anupam Dhasmana; Ruchir Kant; Ritu Trivedi; Prem M S Chauhan
Journal:  Medchemcomm       Date:  2018-06-12       Impact factor: 3.597

Review 3.  Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism.

Authors:  Srabani Pal; Ashish Bhattacharjee; Asif Ali; Narayan C Mandal; Subhash C Mandal; Mahadeb Pal
Journal:  J Inflamm (Lond)       Date:  2014-08-09       Impact factor: 4.981

4.  NF-κB inhibitors from Eurycoma longifolia.

Authors:  Thi Van Anh Tran; Clemens Malainer; Stefan Schwaiger; Atanas G Atanasov; Elke H Heiss; Verena M Dirsch; Hermann Stuppner
Journal:  J Nat Prod       Date:  2014-01-27       Impact factor: 4.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.